FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387660812> ?p ?o ?g. }

• W4387660812 abstract "Treatment satisfaction in diabetes management is vital to achieving long-term clinical outcomes. This analysis evaluated treatment satisfaction among patients with type 2 diabetes (T2D) after 52 weeks of treatment with once-weekly tirzepatide (5, 10, and 15 mg) compared with dulaglutide 0.75 mg.This exploratory analysis of the phase 3 SURPASS J-mono trial assessed treatment satisfaction using the Japanese translation of the Diabetes Treatment Satisfaction Questionnaire status (DTSQs) and change versions (DTSQc). Subgroup analyses were post hoc and conducted for the DTSQc overall treatment satisfaction score based on age (< 65 or ≥ 65 years), sex (male or female), baseline body mass index (BMI; < 25 or ≥ 25 kg/m2), and baseline glycated hemoglobin (≤ 8.5% or > 8.5%).Baseline DTSQs scores were similar among patients across all treatment arms. Overall, trends showed higher satisfaction among patients who received any tirzepatide dose compared with those who received dulaglutide after 52 weeks of treatment. Mean overall DTSQc treatment satisfaction scores at week 52 were significantly higher with tirzepatide 5, 10, and 15 mg versus dulaglutide 0.75 mg (11.5, 12.1, and 12.3, respectively, vs 8.9; P < 0.001). The DTSQc perceived frequency scores for unacceptable hyperglycemia were significantly lower with tirzepatide 5, 10, and 15 mg versus dulaglutide 0.75 mg (- 1.7, - 1.8, and - 2.3, respectively, vs - 0.6; P < 0.001), while scores for unacceptable hypoglycemia were similar across all treatment arms, ranging from - 0.8 to - 1.1. Subgroup analyses showed increased treatment satisfaction with tirzepatide compared with dulaglutide in the < 65 years (P < 0.001) and baseline BMI ≥ 25 kg/m2 subgroups (P < 0.01 or < 0.001) and similar treatment satisfaction across treatment arms in the ≥ 65 years and BMI < 25 kg/m2 subgroups.Patients with T2D reported higher treatment satisfaction with once-weekly tirzepatide (5, 10, and 15 mg) compared with dulaglutide 0.75 mg after 52 weeks of treatment.ClinicalTrials.gov, NCT03861052." @default.
• W4387660812 created "2023-10-17" @default.
• W4387660812 creator A5018046892 @default.
• W4387660812 creator A5053080474 @default.
• W4387660812 creator A5065510246 @default.
• W4387660812 date "2023-10-16" @default.
• W4387660812 modified "2023-10-17" @default.
• W4387660812 title "Treatment Satisfaction and Quality of Life with Tirzepatide Versus Dulaglutide Among Japanese Patients with Type 2 Diabetes: Exploratory Evaluation of the SURPASS J-mono Trial" @default.
• W4387660812 cites W2062694136 @default.
• W4387660812 cites W2075551307 @default.
• W4387660812 cites W2101039355 @default.
• W4387660812 cites W2119080112 @default.
• W4387660812 cites W2123850120 @default.
• W4387660812 cites W2149435665 @default.
• W4387660812 cites W2770705944 @default.
• W4387660812 cites W2801605705 @default.
• W4387660812 cites W2883028824 @default.
• W4387660812 cites W2993741222 @default.
• W4387660812 cites W3044697752 @default.
• W4387660812 cites W3177122952 @default.
• W4387660812 cites W3177393241 @default.
• W4387660812 cites W3191712049 @default.
• W4387660812 cites W3205201678 @default.
• W4387660812 cites W4210940103 @default.
• W4387660812 cites W4211009683 @default.
• W4387660812 cites W4220744584 @default.
• W4387660812 cites W4229060143 @default.
• W4387660812 cites W4281680233 @default.
• W4387660812 cites W4288735703 @default.
• W4387660812 cites W4288740467 @default.
• W4387660812 cites W4324333869 @default.
• W4387660812 cites W4324334056 @default.
• W4387660812 doi "https://doi.org/10.1007/s13300-023-01485-3" @default.
• W4387660812 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37843771" @default.
• W4387660812 hasPublicationYear "2023" @default.
• W4387660812 type Work @default.
• W4387660812 citedByCount "0" @default.
• W4387660812 crossrefType "journal-article" @default.
• W4387660812 hasAuthorship W4387660812A5018046892 @default.
• W4387660812 hasAuthorship W4387660812A5053080474 @default.
• W4387660812 hasAuthorship W4387660812A5065510246 @default.
• W4387660812 hasBestOaLocation W43876608121 @default.
• W4387660812 hasConcept C126322002 @default.
• W4387660812 hasConcept C134018914 @default.
• W4387660812 hasConcept C141071460 @default.
• W4387660812 hasConcept C1862650 @default.
• W4387660812 hasConcept C187960798 @default.
• W4387660812 hasConcept C2775944032 @default.
• W4387660812 hasConcept C2777180221 @default.
• W4387660812 hasConcept C2777538456 @default.
• W4387660812 hasConcept C2779306644 @default.
• W4387660812 hasConcept C2779829264 @default.
• W4387660812 hasConcept C2780221984 @default.
• W4387660812 hasConcept C2780533449 @default.
• W4387660812 hasConcept C2780668416 @default.
• W4387660812 hasConcept C44249647 @default.
• W4387660812 hasConcept C555293320 @default.
• W4387660812 hasConcept C67761136 @default.
• W4387660812 hasConcept C71924100 @default.
• W4387660812 hasConceptScore W4387660812C126322002 @default.
• W4387660812 hasConceptScore W4387660812C134018914 @default.
• W4387660812 hasConceptScore W4387660812C141071460 @default.
• W4387660812 hasConceptScore W4387660812C1862650 @default.
• W4387660812 hasConceptScore W4387660812C187960798 @default.
• W4387660812 hasConceptScore W4387660812C2775944032 @default.
• W4387660812 hasConceptScore W4387660812C2777180221 @default.
• W4387660812 hasConceptScore W4387660812C2777538456 @default.
• W4387660812 hasConceptScore W4387660812C2779306644 @default.
• W4387660812 hasConceptScore W4387660812C2779829264 @default.
• W4387660812 hasConceptScore W4387660812C2780221984 @default.
• W4387660812 hasConceptScore W4387660812C2780533449 @default.
• W4387660812 hasConceptScore W4387660812C2780668416 @default.
• W4387660812 hasConceptScore W4387660812C44249647 @default.
• W4387660812 hasConceptScore W4387660812C555293320 @default.
• W4387660812 hasConceptScore W4387660812C67761136 @default.
• W4387660812 hasConceptScore W4387660812C71924100 @default.
• W4387660812 hasLocation W43876608121 @default.
• W4387660812 hasLocation W43876608122 @default.
• W4387660812 hasOpenAccess W4387660812 @default.
• W4387660812 hasPrimaryLocation W43876608121 @default.
• W4387660812 hasRelatedWork W2869651365 @default.
• W4387660812 hasRelatedWork W2915644543 @default.
• W4387660812 hasRelatedWork W2965907707 @default.
• W4387660812 hasRelatedWork W2966269748 @default.
• W4387660812 hasRelatedWork W2966308070 @default.
• W4387660812 hasRelatedWork W2968054001 @default.
• W4387660812 hasRelatedWork W4236193911 @default.
• W4387660812 hasRelatedWork W4244376057 @default.
• W4387660812 hasRelatedWork W4253648762 @default.
• W4387660812 hasRelatedWork W4286312122 @default.
• W4387660812 isParatext "false" @default.
• W4387660812 isRetracted "false" @default.
• W4387660812 workType "article" @default.